Clinical trial
Study Comparing Full-dose Radiotherapy Versus Reduced Dose in the Management of…
NCT00172029 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00172029 |
|---|---|
| Title | Study Comparing Full-dose Radiotherapy Versus Reduced Dose in the Management of Bone Metastasis in Patients With Breast Cancer Receiving Zoledronic Acid |
| Official title | Study Comparing Full-dose Radiotherapy Versus Reduced Dose in the Management of Bone Metastasis in Patients With Breast Cancer Receiving Zoledronic Acid |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Breast Cancer With Metastatic Bone Disease |
| Intervention type | Drug |
| Interventions | Zoledronic acid |
| Enrollment | 116 |
| Start date | Apr 1, 2003 |
| Primary completion | Sep 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | Aug 18, 2023 |
| Countries | Turkey (Türkiye) |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: